rs41305898

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_032119.4(ADGRV1):​c.4214C>T​(p.Ser1405Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00136 in 1,613,382 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 5 hom. )

Consequence

ADGRV1
NM_032119.4 missense

Scores

1
9
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:8

Conservation

PhyloP100: 4.97

Publications

10 publications found
Variant links:
Genes affected
ADGRV1 (HGNC:17416): (adhesion G protein-coupled receptor V1) This gene encodes a member of the G-protein coupled receptor superfamily. The encoded protein contains a 7-transmembrane receptor domain, binds calcium and is expressed in the central nervous system. Mutations in this gene are associated with Usher syndrome 2 and familial febrile seizures. Several alternatively spliced transcripts have been described. [provided by RefSeq, Jul 2008]
ADGRV1 Gene-Disease associations (from GenCC):
  • Usher syndrome type 2
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 2C
    Inheritance: AR Classification: STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • febrile seizures, familial, 4
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.023018152).
BP6
Variant 5-90653788-C-T is Benign according to our data. Variant chr5-90653788-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 46325.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.00138 (2021/1461122) while in subpopulation MID AF = 0.0116 (67/5768). AF 95% confidence interval is 0.00938. There are 5 homozygotes in GnomAdExome4. There are 1028 alleles in the male GnomAdExome4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 5 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADGRV1NM_032119.4 linkc.4214C>T p.Ser1405Phe missense_variant Exon 20 of 90 ENST00000405460.9 NP_115495.3 Q8WXG9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADGRV1ENST00000405460.9 linkc.4214C>T p.Ser1405Phe missense_variant Exon 20 of 90 1 NM_032119.4 ENSP00000384582.2 Q8WXG9-1
ADGRV1ENST00000640403.1 linkc.1505C>T p.Ser502Phe missense_variant Exon 10 of 29 5 ENSP00000492531.1 A0A1W2PRC7
ADGRV1ENST00000504142.2 linkn.2980C>T non_coding_transcript_exon_variant Exon 14 of 14 5
ADGRV1ENST00000639676.1 linkn.1812C>T non_coding_transcript_exon_variant Exon 8 of 11 5

Frequencies

GnomAD3 genomes
AF:
0.00108
AC:
165
AN:
152142
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000290
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00187
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00165
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00115
AC:
285
AN:
247792
AF XY:
0.00136
show subpopulations
Gnomad AFR exome
AF:
0.000130
Gnomad AMR exome
AF:
0.000525
Gnomad ASJ exome
AF:
0.000199
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000186
Gnomad NFE exome
AF:
0.00188
Gnomad OTH exome
AF:
0.00216
GnomAD4 exome
AF:
0.00138
AC:
2021
AN:
1461122
Hom.:
5
Cov.:
32
AF XY:
0.00141
AC XY:
1028
AN XY:
726724
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33476
American (AMR)
AF:
0.000717
AC:
32
AN:
44602
Ashkenazi Jewish (ASJ)
AF:
0.000230
AC:
6
AN:
26116
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.00127
AC:
109
AN:
86106
European-Finnish (FIN)
AF:
0.000187
AC:
10
AN:
53370
Middle Eastern (MID)
AF:
0.0116
AC:
67
AN:
5768
European-Non Finnish (NFE)
AF:
0.00152
AC:
1685
AN:
1111644
Other (OTH)
AF:
0.00176
AC:
106
AN:
60346
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
111
222
333
444
555
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00110
AC:
168
AN:
152260
Hom.:
0
Cov.:
32
AF XY:
0.00106
AC XY:
79
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.000289
AC:
12
AN:
41566
American (AMR)
AF:
0.00124
AC:
19
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00165
AC:
112
AN:
68008
Other (OTH)
AF:
0.00332
AC:
7
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
8
16
25
33
41
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00149
Hom.:
0
Bravo
AF:
0.00112
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000536
AC:
2
ESP6500EA
AF:
0.00158
AC:
13
ExAC
AF:
0.00109
AC:
132
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:4
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ADGRV1: BP4, BS2 -

Nov 21, 2016
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 01, 2019
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 05, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 22135276) -

Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Mar 19, 2020
Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 28, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Ser1405Phe in exon 20 of GPR98: This variant is not likely to have clinical si gnificance because it was identified in 0.17% (104/61754) European chromosomes b y the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs41305898). -

Retinal dystrophy Uncertain:1
Jan 01, 2019
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg
Significance:Uncertain significance
Review Status:flagged submission
Collection Method:clinical testing

- -

Usher syndrome type 2C Benign:1
Apr 08, 2025
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ADGRV1-related disorder Benign:1
Sep 14, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Uncertain
0.010
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.40
T;T;.
Eigen
Uncertain
0.49
Eigen_PC
Uncertain
0.45
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.71
.;T;T
M_CAP
Uncertain
0.19
D
MetaRNN
Benign
0.023
T;T;T
MetaSVM
Benign
-1.2
T
PhyloP100
5.0
PrimateAI
Benign
0.44
T
PROVEAN
Uncertain
-2.7
.;D;.
REVEL
Uncertain
0.40
Sift
Uncertain
0.0030
.;D;.
Sift4G
Pathogenic
0.0
.;D;.
Polyphen
1.0
D;D;.
Vest4
0.85
MVP
0.71
MPC
0.20
ClinPred
0.10
T
GERP RS
4.6
Varity_R
0.40
gMVP
0.85
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41305898; hg19: chr5-89949605; COSMIC: COSV67983309; COSMIC: COSV67983309; API